Share This

Related Topics News -

     
 < Previous page   Title only   |   Print 
     
復旦張江(01349.HK)用於腦膠質瘤手術可視化藥物獲批臨床

2023-12-27T  
復旦張江(01349.HK):用於膀胱癌手術可視化藥物臨床試驗申請獲受理

2023-12-18T  
《公司業績》復旦張江首三季純利8,989.16萬元人民幣升144.1%

2023-10-30T  
復旦張江用於治療晚期實體瘤藥物獲藥監局受理臨床試驗申請

2023-10-20T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.